Daratumumab: A drug with transfusion dilemma

Daratumumab: A drug with transfusion dilemma

Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma (RRMM). DARA interferes with blood compatibility testing by causing incompatible results while crossmatching by antihuman globulin phase and presenting as a panagglutination...

Full description

Bibliographic Details
Main Authors: Amit Kumar Biswas, Anurag Gairola, Ajay Kumar Baranwal, Rajat Jagani, Amit Ajay Pawar, Ujjwal Dimri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Global Journal of Transfusion Medicine
Subjects:
2-mercaptoethanol
daratumumab
panagglutination
relapsed refractory multiple myeloma
Online Access:http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=2;spage=222;epage=226;aulast=Biswas

Internet

http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=2;spage=222;epage=226;aulast=Biswas

Similar Items